Skip to Content
Home » Medical Areas » Surgical Site Infection Risk Factors

Surgical Site Infection Risk Factors

Related Products: 
Coated VICRYL* Plus Antibacterial (polyglactin 910) Suture
DERMABOND ADVANCED™ Topical Skin Adhesive
MONOCRYL* Plus Antibacterial (poliglecaprone 25) Suture
PDS* Plus Antibacterial (polydioxanone) Suture
Related Specialties: 
Cardiovascular
Emergency Medicine
General Surgery
Infectious Disease
Neurosurgery
Trauma & Acute Surgery
Urology

Surgical Site Infection Risk FactorsSurgical Site Infection Risk Factors

Address External Risk Factors for Surgical Site Infections (SSIs)

SSIs are a major source of infection in the hospital setting1 and the complications that can cause morbidity and mortality. SSIs can:

  • In one orthopedic study, increase the length of stay for a patient by an average of 7 to 19.5 days2
  • Increase the overall cost of a surgical procedure by tens of thousands of dollars per case3
  • Increase the likelihood of ICU admission by 60%4
  • Double the risk of mortality4

Maximize the Care, Minimize the Costs
Addressing key preoperative, perioperative, and postoperative external risk factors can help to prevent SSIs. Preparing the patient and surgical team, sanitizing the operating theater, keeping the general operating environment clean, using the latest antimicrobial technology, and optimizing in-hospital recovery can all help to minimize the risk. The goal is to improve patient quality of care and minimize unnecessary healthcare costs.

Ethicon provides products including Plus Antibacterial sutures; DERMABOND® Topical Skin Adhesive, and ETHIGUARD* Blunt Point Needle that help address some of the risk factors associated with Surgical Site Infection.

Ethicon™ Biosurgery provides the first and only absorbable hemostat (SURGICEL® Family of Absorbable Hemostats) that is proven bactericidal against a broad range of gram-positive and gram-negative organisms including various antibiotic-resistant bacteria (MRSA, VRE, PRSP and MRSE)5, 6


‡CFU=Colony Forming Units

To learn more, please click on the product(s) in the adjacent list of offerings to minimize risk factors associated with surgical site infection.

References
1. Klevens RM, Edwards JR, Richards CL Jr, et al. Estimating healthcare-associated infections and deaths in US hospitals, 2002. Public Health Rep. 2007;122(2):160-166.
2. Whitehouse JD, Friedman ND, Kirkland KB, Richardson WJ, Sexton DJ. The impact of surgical-site infections following orthopedic surgery at a community hospital and a university hospital: adverse quality of life, excess length of stay, and extra cost. Infect Control Hosp Epidemiol. 2002;23(4):183-189.
3. Fry DE. The economic costs of surgical site infection. Surg Infect. 2002;3(suppl 1):S37-S43.
4. Bratzler DW, Houck PM; for Surgical Infection Prevention Guideline Writers Workgroup. Antimicrobial prophylaxis for surgery: an advisory statement from the National Surgical Infection Prevention Project. Clin Infect Dis. 2004;38(12):1706-1715.
5. Spangler D, Rothenburger S, Nguyen K, Jampani H, Weiss S, Bhende S. In vitro antimicrobial activity of oxidized regenerated cellulose against antibiotic-resistant microorganisms. Surg Infect. 203; 4(3): 255-262.
6. Data on file, Ethicon, Inc. in vivo study.
 
*Trademark